Hindilerden, F. Et Al. 2019. The Clinical Significance of JAK2V617F Mutation for Philadelphia-Negative Chronic Myeloproliferative Neoplasms in Patients with Splanchic Vein Thrombosis. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19 .

Hindilerden, F., Hindilerden, I. Y., Pinarbasi, B., HANÇER, V. S., Kaymakoglu, S., Kucukkaya, R. D., ... Nalcaci, M.(2019). The Clinical Significance of JAK2V617F Mutation for Philadelphia-Negative Chronic Myeloproliferative Neoplasms in Patients with Splanchic Vein Thrombosis. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19.

Hindilerden, Fehmi Et Al. "The Clinical Significance of JAK2V617F Mutation for Philadelphia-Negative Chronic Myeloproliferative Neoplasms in Patients with Splanchic Vein Thrombosis," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19, 2019

Hindilerden, Fehmi Et Al. "The Clinical Significance of JAK2V617F Mutation for Philadelphia-Negative Chronic Myeloproliferative Neoplasms in Patients with Splanchic Vein Thrombosis." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19, 2019

Hindilerden, F. Et Al. (2019) . "The Clinical Significance of JAK2V617F Mutation for Philadelphia-Negative Chronic Myeloproliferative Neoplasms in Patients with Splanchic Vein Thrombosis." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19.

@article{article, author={Fehmi Hindilerden Et Al. }, title={The Clinical Significance of JAK2V617F Mutation for Philadelphia-Negative Chronic Myeloproliferative Neoplasms in Patients with Splanchic Vein Thrombosis}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2019}